19:
Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates.
Hiraki T, Gobara H, Iishi T, Sano Y, Iguchi T, Fujiwara H, Tajiri N, Sakurai J, Date H, Mimura H, Kanazawa S.
J Thorac Cardiovasc Surg. 2007 Nov;134(5):1306-12.
PMID: 17976467 [PubMed - indexed for MEDLINE]
Related Articles
20:
Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer.
Banki F, Mason RJ, Oh D, Hagen JA, DeMeester SR, Lipham JC, Tanaka K, Danenberg KD, Yacoub WN, Danenberg PV, DeMeester TR.
Arch Surg. 2007 Jun;142(6):533-8; discussion 538-9.
PMID: 17576889 [PubMed - indexed for MEDLINE]
Related Articles